Has William Irvine, MD received payments from drug or device companies?

Yes. Drug and device makers reported $10,733 in general payments to William Irvine, MD across 232 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean William Irvine, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about William Irvine, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

William Irvine, MD

Ophthalmology · Jackson, TNNPI 1760488498

Payments from drug & device makers

$10,733in general payments, 2019–2025

Across 232 payments — averaging $46.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Rxsight Inc$5K
AbbVie$935
Regeneron Healthcare Solutions, Inc.$554
Apellis Pharmaceuticals, Inc.$451
Notal Vision, Inc.$376
Mallinckrodt Hospital Products Inc.$357
plus $3K from 30 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Rxsight Inc	4	$5,344
AbbVie(2 entities)	48	$935
Regeneron Healthcare Solutions, Inc.	10	$554
Apellis Pharmaceuticals, Inc.	19	$451
Notal Vision, Inc.	1	$376
Mallinckrodt Hospital Products Inc.	17	$357
Bausch & Lomb Americas Inc.	17	$332
Genentech USA, Inc.	11	$306
Alimera Sciences, Inc.	11	$213
Bausch & Lomb, A Division Of Bausch Health US, LLC	15	$204
Harrow Eye, LLC	8	$161
Ocular Therapeutix, Inc.	7	$151
Amgen(2 entities)	2	$147
Novartis	9	$144
ANI Pharmaceuticals, Inc.	5	$96
Shire North American Group Inc	5	$90
Johnson & Johnson Surgical Vision, Inc.	4	$89
Aerie Pharmaceuticals, Inc.	6	$88
Dompe US, Inc.	3	$86
Oyster Point Pharma, Inc.	4	$77
Boston Scientific	2	$62
Thea Pharma Inc.	3	$61
Coherus Oncology, Inc.	3	$57
Alcon	3	$49
Biotissue Holdings Inc.	2	$40
Beaver-visitec International, Inc.	1	$39
Dutch Ophthalmic, USA	1	$30
Kala Pharmaceuticals, Inc.	2	$28
Sun Pharmaceutical Industries Inc.	2	$28
Tarsus Pharmaceuticals, Inc.	1	$27
Biogen	1	$27
Astellas Pharma US Inc	1	$22
Mallinckrodt Enterprises LLC	1	$20
Rayner Intraocular Lenses Limited	1	$15
Glaukos Corporation	1	$15
Eyevance Pharmaceuticals LLC	1	$15

How this compares

$10,733 in reported general payments places this provider in the 85th percentile of 323 ophthalmology providers in Tennessee.

See all ophthalmology providers in Tennessee →

Medicare billing

Part B allowed, 2024

$1,177,211

Medicare patients

1,236

Services billed

11,435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Jackson

Laura DipumaJackson$8K
Brian BiesmanNashville$3.2M
Deborah ShermanNashville$3.1M
Gary JerkinsNashville$2.9M
Melissa ToyosMemphis$2.1M
Jeffrey HornNashville$1.2M
Jeffrey KammerNashville$919K
Rolando ToyosMemphis$849K
Kenneth OlanderMaryville$637K
Charles KirbyChattanooga$614K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →